Kensey Nash withdraws FY2012 guidance on St Jude Angio-Seal royalty row
This article was originally published in Clinica
Executive Summary
Kensey Nash has withdrawn its financial guidance for the rest of fiscal year 2012 as it seeks to resolve a dispute with St Jude Medical over royalty fees for the Angio-Seal vascular closure device.
Register for our free email digests: